MedPath

Preventing Diabetic Osteoporosis With Exercise

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Combination Product: Behavior intervention of uphill exercise
Combination Product: Behavioral intervention of downhill exercise
Combination Product: Dietary intervention of uphill exercise
Combination Product: Behavioral intervention of sedentary no-exercise trial
Combination Product: Behavior intervention of downhill exercise
Combination Product: Dietary intervention of exercise before the meal
Combination Product: Dietary intervention of exercise after the meal
Combination Product: Dietary intervention of eating two meals
Registration Number
NCT03930758
Lead Sponsor
University of Michigan
Brief Summary

The two specific aims of the study were to determine whether:

1. Greater mechanical loading of downhill exercise will increase the osteogenic index (ratio between CICP, the marker of bone formation (c-terminal propeptide of type I collagen, and CTX, the marker of bone resorption (c terminal telopeptide of type I collagen)) to a greater extent than uphill exercise that provides lower ground-reaction force;

2. Exercise after the meals will induce greater osteogenic response than exercise pefore the meals as it is known that meal eating during daytime inhibits bvone resorption markers.

Detailed Description

The study addresses the problem that postmenopausal women with type 2 diabetes have a higher incidence of bone breaks despite their often normal bone mineral density (BMD).

The investigators pursued two hypotheses, that:

1. 40-minute bout of downhill exercise will increase the CICP/CTX osteogenic index to a greater extent than the same amount of uphill exercise; and

2. Performing exercise one hour after the meals will be more osteogenic than exercise before the meals.

Subjects were 15 postmenopausal women with type 2 diabetes, age 57.7 years, BMI 27.2 kg/m2 who were randomly assigned to two out of 5 trials:

Uphill exercise before the meals (UBM), Uphill exercise after the meals (UAM), Downhill exercise before the meals (DBM), Downhill exercise after the meals (DAM), and Sedentary, no-exercise, trial (SED). All subjects signed an informed consent approved by the University of Michigan Medical School Institutional Review Board. Subjects had their BMD measured with DXA at the outset.

Weight-maintenance meals contained 50% carbohydrate, 15% protein, and 25% fat and were provided at 10 h and 17 h. Exercise (40 minutes at 50% of maximal effort) on either uphill (+6o slope) or downhill treadmill (-6o slope) was performed either before the two meals, at 9 h and 16 h, respectively, or after the meals. at 11 h and 18 h, respectively.

Blood was drawn through an intravenous catheter from ante-cubital vein at hourly intervals between 8 and 20 h with two additional blood draws at 0 h and 6 h the next morning. Blood was treated with protease inhibitors, and plasma, frozen at -80o C, was used to measure bone markers, CICP, CTX, osteocalcin , and bone-specific alkaline phosphatase using Millipore chemoluminescen reagents, glucose by glucose oxidase, and hormones insulin, cortisol, parathyroid hormone (PTH) , and growth hormone (GH) by radio-immunoassays..

Mixed-model ANOVA was used for analysis of outcome measures where the trial procedures served as fixed variable and individual subjects as intercept variables.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
15
Inclusion Criteria

postmenopausal type-2 diabetes melllitus age between 50 and 65 exercise less than 20 minutes three times a week

Read More
Exclusion Criteria

metabolic disease other than type-2 diabetes and hormonally-corrected hypothyroidism musculo-skeletal disability that would preclude exercise smoker do not meet inclusion criteria

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Uphill exercise before the mealsDietary intervention of exercise before the meal40 minutes of uphill treadmill exercise at +6o slope completed 1 hour before eating the meal
Uphill exercise after the mealsDietary intervention of exercise after the meal40 minutes of uphill treadmill exercise at +6o slope started 1 hour after eating the meal
Uphill exercise before the mealsBehavior intervention of uphill exercise40 minutes of uphill treadmill exercise at +6o slope completed 1 hour before eating the meal
Downhill exercise after the mealsBehavioral intervention of downhill exercise40 minutes of downhill treadmill exercise at -6o slope started 1 hour after eating the meal
Uphill exercise after the mealsDietary intervention of uphill exercise40 minutes of uphill treadmill exercise at +6o slope started 1 hour after eating the meal
Downhill exercise before the mealsDietary intervention of exercise before the meal40 minutes of downhill treadmill exercise at -6o slope completed 1 hour before eating the meal
Sedentary trialBehavioral intervention of sedentary no-exercise trialA trial with no exercise
Downhill exercise before the mealsBehavior intervention of downhill exercise40 minutes of downhill treadmill exercise at -6o slope completed 1 hour before eating the meal
Downhill exercise after the mealsDietary intervention of exercise after the meal40 minutes of downhill treadmill exercise at -6o slope started 1 hour after eating the meal
Sedentary trialDietary intervention of eating two mealsA trial with no exercise
Primary Outcome Measures
NameTimeMethod
C-terminal telopeptide of type 1 collagenHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of c-terminal telopeptide of type 1 collagen (ng/ml)

C-terminal propeptide of type I collagenHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of c-terminal propeptde of type 1 collagen (ng/ml)

OsteocalcinHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of osteocalcin (ng/ml)

Bone-specific alkaline phosphataseHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of bone-specific alkaline phosphatase (ng/ml)

Secondary Outcome Measures
NameTimeMethod
CortisolHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of cortisol (m/L)

GlucoseHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of glucose (mg/dl)

InsulinHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of insulin (µU/ml)

Parathyroid hormoneHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of parathyroid hormone (ng/ml)

Dual-energy X-ray radiographyA week prior to the study baseline

Whole-body dual-energy X-ray radiography scan

Growth hormoneHourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial

Change over time in plasma concentration of growth hormone (ng/ml)

Novel PedarDuring two one-hour bouts of the exercise intervention

Mechanosensitive shoe inserts for measurement of ground reaction force

© Copyright 2025. All Rights Reserved by MedPath